Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire.
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
J Surg Res. 2023 Mar;283:1073-1077. doi: 10.1016/j.jss.2022.11.040. Epub 2022 Dec 14.
Intraoperative parathyroid hormone (IOPTH) monitoring is routinely used to facilitate minimally invasive parathyroidectomy. Many IOPTH protocols exist for predicting biochemical cure. Some patients are found to have extremely high baseline IOPTH levels (defined in this study as >500 pg/mL), which may affect the likelihood of satisfying certain final IOPTH criteria. We aimed to discover whether clinically significant differences exist in patients with extremely high baseline IOPTH and which IOPTH protocols are most appropriately applied to these patients.
This is a retrospective review of 237 patients who underwent parathyroidectomy with IOPTH monitoring for primary hyperparathyroidism (pHPT) from 2016 to 2020. Baseline IOPTH levels, drawn prior to manipulation of parathyroid glands, were grouped into categories labeled "elevated" (>65-500 pg/mL) and "extremely elevated" (>500 pg/mL). Final IOPTH levels were analyzed to determine whether there was a >50% decrease from baseline and whether a normal IOPTH value was achieved. 6-wk postoperative calcium levels were also examined.
Of the patients in this cohort, 76% were in the elevated group and 24% in the extremely elevated group. Male sex and higher preoperative PTH levels were correlated with higher baseline IOPTH levels. Patients with extremely elevated baseline IOPTH were less likely to have IOPTH fall into normal range at the conclusion of the case (P = 0.019), and final IOPTH levels were higher (P < 0.001), but the IOPTH was equally likely to decrease >50% from baseline. There was no difference in the mean postoperative calcium levels between the two groups at 6-wk or at longer term follow-up (mean 525 d).
Detection of baseline IOPTH levels >500 pg/mL during parathyroidectomy performed for pHPT is not uncommon. IOPTH in patients with extremely elevated baseline levels were less likely to fall into normal range, but follow-up calcium levels were equal, suggesting that applying more stringent IOPTH criteria for predicting biochemical cure may not be appropriate for this population.
术中甲状旁腺激素(IOPTH)监测通常用于辅助微创甲状旁腺切除术。目前已有多种 IOPTH 方案用于预测生化治愈。一些患者的基础 IOPTH 水平极高(本研究中定义为>500pg/mL),这可能会影响满足某些最终 IOPTH 标准的可能性。我们旨在研究基础 IOPTH 极高的患者是否存在临床显著差异,以及哪些 IOPTH 方案最适用于这些患者。
这是一项对 2016 年至 2020 年间接受 IOPTH 监测的甲状旁腺切除术治疗原发性甲状旁腺功能亢进症(pHPT)的 237 例患者的回顾性研究。在操作甲状旁腺之前抽取的基础 IOPTH 水平被分为“升高”(>65-500pg/mL)和“极高”(>500pg/mL)两类。分析最终 IOPTH 水平以确定是否较基础值降低>50%,以及是否达到正常 IOPTH 值。还检查了术后 6 周的血钙水平。
在该队列中,76%的患者处于升高组,24%的患者处于极高组。男性和较高的术前甲状旁腺激素水平与较高的基础 IOPTH 水平相关。基础 IOPTH 极高的患者在手术结束时 IOPTH 更不可能进入正常范围(P=0.019),最终 IOPTH 水平更高(P<0.001),但 IOPTH 从基础值降低>50%的可能性相同。两组患者术后 6 周或长期随访(平均 525 天)的血钙水平无差异。
在 pHPT 行甲状旁腺切除术期间检测到 IOPTH 基础值>500pg/mL 并不罕见。基础 IOPTH 极高的患者更不可能进入正常范围,但随访的血钙水平相同,这表明对于这部分人群,应用更严格的 IOPTH 标准预测生化治愈可能不合适。